Pier Capital’s Idexx Laboratories IDXX Stock Holding History

Pier Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.11K	Hold	4	–	–	﹤0.01%	128
2026 Q1	$2.25K	Hold	4	–	–	﹤0.01%	121
2025 Q4	$2.71K	Sell	4 -8	-67%	-$5.45K	﹤0.01%	120
2025 Q3	$7.67K	Hold	12	–	–	﹤0.01%	122
2025 Q2	$6.44K	Hold	12	–	–	﹤0.01%	115
2025 Q1	$5.04K	Hold	12	–	–	﹤0.01%	113
2024 Q4	$4.96K	Hold	12	–	–	﹤0.01%	117
2024 Q3	$6.06K	Hold	12	–	–	﹤0.01%	127
2024 Q2	$5.85K	Hold	12	–	–	﹤0.01%	125
2024 Q1	$6.48K	Hold	12	–	–	﹤0.01%	124
2023 Q4	$6.66K	Buy	12 +3	+33%	+$1.41K	﹤0.01%	115
2023 Q3	$3.94K	Hold	9	–	–	﹤0.01%	117
2023 Q2	$4.52K	Buy	+9	New	+$4.31K	﹤0.01%	114

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Pier Capital's IDXX Position: Q2 2026 in Review

Pier Capital held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 4 shares worth $2.11K. The position accounts for ﹤0.01% of the portfolio, ranked #128.

Pier Capital first reported a position in IDXX in Q2 2023 and has held it in 13 quarters since. The position peaked at $7.67K in Q3 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Pier Capital held 4 shares of Idexx Laboratories worth $2.11K as of Q2 2026.
Pier Capital left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up ﹤0.01% of Pier Capital's portfolio in Q2 2026, its #128 holding.
Pier Capital first reported a position in Idexx Laboratories in Q2 2023 and has held it in 13 quarters since.
Pier Capital's Idexx Laboratories position peaked at $7.67K in Q3 2025.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Pier Capital's 13F filing for Q2 2026, filed 5 Aug 2026.